Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2006 of 6351
-
Could a cheap pill replace IV drips for ulcer bleeding?
Disease control Recruiting nowPeptic ulcer bleeding is the most common etiology in upper gastrointestinal bleeding all over the world. After endoscopic treatment, proton pump inhibitor (PPI) is recommended to prevent re-bleeding. Intravenous PPI is recommended as a standard treatment. In the past, there were …
Sponsor: King Chulalongkorn Memorial Hospital • Aim: Disease control
Last updated Jun 26, 2026 17:53 UTC
-
A dye that lights up blood flow may help surgeons save limbs and prevent infection
Diagnosis CompletedThis is a prospective observational study that will evaluate the association between bone and tissue perfusion, as measured by indocyanine green (ICG) fluorescence imaging, and complications, in an effort to develop ICG fluorescence imaging as a diagnostic tool to quantitatively …
Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Diagnosis
Last updated Jul 31, 2026 00:00 UTC
-
Tiny brain implant could replace major surgery for fluid buildup
Disease control OngoingThe eShunt™ System is a minimally invasive method of treating communicating hydrocephalus. The eShunt System includes a proprietary eShunt Delivery System and the eShunt Implant, a permanent implant deployed in a minimally invasive, neuro-interventional procedure. The eShunt Impl…
Sponsor: CereVasc Inc • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New pill targets Alzheimer's in High-Risk gene carriers
Disease control CompletedThe study will investigate the effects of oral ALZ-801, in subjects with Early AD who have the APOE4/4 or APOE3/4 genotype, on the biomarkers of core AD pathology. The objectives of this study include determining the efficacy and safety/tolerability of ALZ-801. In addition, the s…
Phase 2 • Sponsor: Alzheon Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Could Lab-Grown eye cells restore sight? new trial begins
Disease control OngoingThis phase I study will collect preliminary information on the activity and safety of cLSC. We will investigate the ability to manufacture and transplant cLSC onto the cornea successfully at the time of surgery (feasibility), and have cLSC begin to populate the ocular surface (ef…
Phase 1 • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Brain scans after stroke may unlock secrets of cognitive decline
Knowledge-focused OngoingThe investigators will perform follow-up on 250 of 500 cases recruited into the ROSE study of cases with deep and lobar intracerebral hemorrhage to perform advanced neuroimaging at 12-24 months post stroke, and evaluations of motor and cognitive function at baseline, 6 months aft…
Sponsor: State University of New York at Buffalo • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Magnetic pulses to the brain: a new hope for depression?
Symptom relief CompletedThis is a randomized, double-blind, sham-controlled multicenter clinical trial. The aim is to provide evidence for efficacy of TBS in the treatment of patients with major depression. There will be a direct comparison between combined cTBS/iTBS with sham TBS. Overall, 236 patients…
Sponsor: University Hospital Tuebingen • Aim: Symptom relief
Last updated Jun 26, 2026 17:29 UTC
-
Could a common laxative soothe gut inflammation in cystic fibrosis?
Disease control Stopped earlyThe main objective of the study is to evaluate the effectiveness of polyethylene glycol treatment on intestinal inflammation in children with cystic fibrosis. In this test, a method adapted from the Fleming one-step scheme will be used. The success rate is measured by the proport…
Phase 2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New therapy targets Brain's 'Orienting' reflex to treat PTSD
Symptom relief OngoingThis study will evaluate the efficacy of a therapeutic treatment, Deep Brain Reorienting (DBR), for PTSD (Post-traumatic Stress Disorder). Participants will be randomized to either the DBR treatment, or wait-list condition.
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
New hope for tough leukemia: experimental drug combo enters human testing
Disease control Recruiting nowThe purpose of this study is to assess the safety, pharmacokinetic profile of Lisaftoclax (APG-2575) single agent and in combination with HHT/AZA in patients with relapsed/refractory AML and related myeloid malignancies.
Phase 1/2 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Robot surgeons take on pancreatic cancer in major trial
Disease control CompletedThis multicenter randomized trial aims to primarily assess and compare the functional recovery of patients who undergo open versus robotic pancreaticoduodenectomy for benign and malignant lesions of the head of the pancreas.
Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New drug aims to tame hard-to-control seizures in rare mitochondrial disorders
Disease control Stopped earlyThis is a parallel-arm, double-blind, placebo-controlled study with a screening phase that includes a 28-day run-in phase to establish baseline seizure frequency, followed by a 24-week, randomized, placebo-controlled phase. After completion of the randomized, placebo-controlled p…
Phase 2/3 • Sponsor: PTC Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Can a phone app keep teens on track with sickle cell treatment?
Disease control CompletedThe primary objective of this study is to evaluate a potential behavioral intervention (MED-Go app). To meet this objective, the researchers will conduct a pilot randomized controlled trial to test the feasibility and acceptability of MED-Go app in adolescents and young adults (A…
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Red light therapy shows promise for Kids' eyesight
Prevention OngoingTo evaluate the long-term efficacy of repeated low-level red-light (RLRL) therapy in the prevention and control of myopia in children, and to analyze the key factors influencing its efficacy (such as individual differences and compliance), with the aim of providing evidence-based…
Sponsor: Ruihua Wei • Aim: Prevention
Last updated Jun 26, 2026 14:54 UTC
-
ALS drug trial halted: what happened with BIIB105?
Disease control Stopped earlyThe ALSpire Study is a clinical trial evaluating the investigational drug BIIB105 in adults living with amyotrophic lateral sclerosis (ALS). The ALSpire Study consists of two parts: * Part 1: 6-month placebo-controlled study. During Part 1, participants are randomly assigned to…
Phase 1/2 • Sponsor: Biogen • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New hope for advanced breast cancer patients after chemotherapy fails
Disease control CompletedThis is a multicenter phase 2 study evaluating the efficacy and safety of trifluridine/tipiracil in women with metastatic or locally advanced breast cancer not amenable to curative treatment by surgery or radiotherapy.
Phase 2 • Sponsor: Borstkanker Onderzoek Groep • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New hope for kids with chronic migraines? drug shows promise in trial
Symptom relief CompletedThe primary objective of the study is to evaluate the effectiveness of fremanezumab as compared to placebo for the preventive treatment of chronic migraine (CM). Secondary objectives are to further demonstrate the efficacy of Fremanezumab as compared to placebo for the preventiv…
Phase 3 • Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
New combo therapy aims to outsmart resistant breast cancer
Disease control OngoingThis phase Ib trial studies the best dose of berzosertib when given together with the usual treatment (radiation therapy) in treating patients with triple negative or estrogen receptor and/or progesterone receptor positive, HER-2 negative breast cancer. Berzosertib may stop the g…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Could a 2-Week radiation blast be as good as 4 weeks for recurrent prostate cancer?
Disease control OngoingThe purpose of this study is to compare urinary and bowel side effects of hypofractionated radiotherapy in 20 treatments (4 weeks) to ultra-hypofractionated radiotherapy in 5 treatments (2 weeks) for prostate cancer that has returned after prostatectomy. The investigators are als…
Phase 2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New hope for kidney patients battling depression: study tests two novel therapies
Disease control OngoingThe overall goal of the study is to determine if treatment of a Major Depressive Disorder (MDD) improves the outcomes of patients with chronic kidney disease (CKD). We showed that MDD is present in 25% of CKD patients and independently associated with progression to End-Stage Kid…
Phase 2 • Sponsor: Stony Brook University • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC